![](/img/cover-not-exists.png)
Ruxolitinib for the treatment of patients with steroid-refractory GVHD: an introduction to the REACH trials
Jagasia, Madan, Zeiser, Robert, Arbushites, Michael, Delaite, Patricia, Gadbaw, Brian, Bubnoff, Nikolas vonLanguage:
english
Journal:
Immunotherapy
DOI:
10.2217/imt-2017-0156
Date:
January, 2018
File:
PDF, 611 KB
english, 2018